HBMK

Hubei Minkang Pharmaceut... (GM) (HBMK)

Hubei Minkang Pharmaceutical Ltd (GM)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:HBMK

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2015/03/31	21 : 55	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2014/08/15	05 : 29	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2014/05/21	05 : 18	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2014/05/17	02 : 39	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2014/04/16	05 : 51	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2014/04/01	06 : 18	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2013/09/19	06 : 01	OTC Markets	Venue Change	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2013/08/15	01 : 21	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2013/08/02	03 : 19	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2013/06/25	01 : 11	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2013/06/11	05 : 45	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2013/05/16	06 : 21	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2013/04/02	01 : 51	Edgar (US Regulatory)	Mutual Fund Summary Prospectus (497k)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2013/04/02	01 : 51	Edgar (US Regulatory)	Quarterly Schedule of Portfolio Holdings of Registered Management Investment Company (n-q)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2013/04/02	01 : 51	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2013/03/28	04 : 22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2013/03/28	04 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2013/03/28	04 : 04	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2013/03/28	03 : 55	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2013/02/01	03 : 21	Edgar (US Regulatory)	Mutual Fund Summary Prospectus (497k)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2013/02/01	03 : 21	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2012/11/20	03 : 15	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2012/11/20	03 : 15	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2012/11/15	04 : 25	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2012/11/15	04 : 25	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2012/09/12	05 : 53	Edgar (US Regulatory)	Amended Quarterly Report (10-Q/A)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2012/08/21	05 : 05	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2012/08/15	02 : 17	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2012/05/19	01 : 27	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)
2012/05/16	06 : 01	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:HBMK	Hubei Minkang Pharmaceutical Ltd (GM)